Viktoria Blumenberg, MD^1,2*, Maria-Luisa Schubert, MD^3*, Eli Zamir^4*, Sabine Schmidt^4*, Roman Rohrbach^4*, Philipp Waldhoff^3*, Daria Bozic^3*, Hendrik Pock, MD^5*, Eran Elinav^4*, Christian Schmidt, MD^1*, Veit Buecklein, MD^1,2*, Carsten Müller-Tidow, MD^3,6*, Peter Dreger, MD³, Michael von Bergwelt, MD, PhD^1,6*, Michael Schmitt, M.D.³, Marion Subklewe, MD^1,2,6 and Christoph Stein-Thöringer, MD^3,4*

¹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
²Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
³Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany
⁴Research Division Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
⁵Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
⁶German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Moriah Rabin, MD¹, Mengyan Li, PhD^2*, Scott Garforth, PhD^3*, Jacqueline Marino, BA^2*, Jian Hua Zheng, BS^2*, Kaitlyn E. O'Connor, BS^2*, Steven C. Almo, PhD^3* and Harris Goldstein, MD^2,4*

¹Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Bronx, NY
²Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY
³Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY
⁴Department of Pediatrics, Children's Hospital at Montefiore, Bronx, NY

Ari Itoh-Nakadai, PhD^1*, Yoriko Saito, MD¹, Mariko Murasawa-Tomizawa^1*, Hiroshi Kajita^1*, Takehisa Matsumoto, Ph.D^2*, Masashi Matsuda, PhD^3*, Takashi Watanabe, PhD^4*, Mikako Shirouzu^2*, Osamu Ohara, PhD^4,5*, Haruhiko Koseki, MD, PhD^3*, Leonard Shultz, PhD^6* and Fumihiko Ishikawa, MD, PhD¹

¹Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
²RIKEN Systems and Structural Biology Center, Yokohama, Japan
³Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
⁴Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
⁵Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan
⁶The Jackson Laboratory, Bar Harbor, ME

Shoji Saito, MD, PhD^1,2, Aiko Hasegawa, Ph.D.^1*, Mika Nagai^1*, Yoichi Inada^1,3*, Hirokazu Morokawa, M.D.^1*, Ikumi Nakashima^1*, Daisuke Morita, M.D., Ph.D.^1,4*, Yuichiro Ide^5*, Kazuyuki Matsuda, PhD^6*, Haruko Tashiro, MD^7*, Shigeki Yagyu, MD, PhD^1,2,8*, Miyuki Tanaka, MD, PhD^1* and Yozo Nakazawa, MD, PhD^1*

¹Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan
²Center for Advanced Research of Gene and Cell Therapy, Shinshu University, Matsumoto, Japan
³Department of Drug Discovery Science, Shinshu University, Matsumoto, Japan
⁴Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, Matsumoto, Japan
⁵Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, JPN
⁶Department of Health and Medical Sciences, Graduate School of Medicine, Shinshu University, Matsumoto, Japan
⁷Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, JPN
⁸Department of Pediatrics, Kyoto Prefectural Medical University, Kyoto, JPN

Leah Alabanza, PhD^*, Bang Vu, PhD^*, Darong Wu, MS^*, Zhongyu Zhu, PhD^*, Boro Dropulic, PhD, MBA^* and Dina Schneider, PhD

Lentigen Technology, Inc., a Miltenyi Biotec Company, Gaithersburg, MD

Wei Jiang, MBBS, M Clin Med, FRACP, FRCPA¹, Emily Blyth, B. Med(Hons), FRACP, FRCPA, PhD^2,3,4*, Peter J. Shaw, MA, FRACP⁵, Leighton Edward Clancy, BSc, PhD^4*, Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA^4,6,7*, Abir Bhattacharyya, MBBS, FRACP, FRCPA^8*, Elissa Atkins, RN^9*, Selmir Avdic, PhD^10*, Gaurav Sutrave, MBBS, FRACP, FRCPA^11*, Janine Street, BSc MSc (Hons)^12* and David Gottlieb, MBBS, MD, FRACP, FRCPA^7*

¹Westmead Institute of Medical Research, Westmead, NSW, Australia
²Westmead Hospital, Blood and Marrow Transplant Unit, Sydney, Australia
³Westmead Institute for Medical Research, University of Sydney, Sydney, Australia
⁴Westmead Hospital, Sydney Cellular Therapies Laboratory, Sydney, Australia
⁵The Children's Hospital at Westmead, The Sydney Children's Hospitals Network, Westmead, Australia
⁶University of Sydney, Sydney, NSW, Australia
⁷Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, NSW, Australia
⁸Dept of Haematology, Westmead Hospital, Sydney, NSW, Australia
⁹Westmead Hospital, Westmead, Australia
¹⁰Westmead Institute for Medical Research, Sydney, Australia
¹¹Westmead Institute of Medical Research, Sydney, AUS
¹²Westmead Institute of Medical Research, Sydney, Australia

Erica Lynne Braverman, MD, Andrea Dobbs, MSc^*, Darlene A. Monlish, PhD^* and Craig Byersdorfer, MD, PhD

Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA

Xiaomei Wang, PhD^*, MyLinh T Duong, PhD^*, Alan D. Guerrero, PhD^*, Aruna Mahendravada, MS^*, Kelly L Sharp, BS^*, Mary E. Brandt, BS^*, Christine Gagliardi, PhD^*, Aaron E. Foster, PhD and J. Henri Bayle, PhD^*

Bellicum Pharmaceuticals, Houston, TX

Sumithra Vasu, MD, MBBS¹, Nelli Bejanyan, MD², Steven M Devine, MD³, Elizabeth O. Hexner, MD, MSTR^4*, Brent Logan, PhD^5*, Leo Luznik, MD⁶, Brittany K. Ragon, MD⁷, Andrew Sandler, MD^8*, Elizabeth F Krakow, MD, MSc⁹, Michael Fitzgerald^8*, Lorraine Tracey, PhD^8* and Richard E. Champlin, MD¹⁰

¹Ohio State University Wexner Medical Center, Columbus, OH
²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³National Marrow Donor Program (NMDP)/Be The Match, Minneapolis, MN
⁴Division of Hematology-Oncology/Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁶Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁷Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁸Kiadis Pharma, Amsterdam, Netherlands
⁹Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁰Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Satoru Aoyama, M.D.^1,2*, Shunichiro Yasuda, M.D.^1,2*, Daisuke Watanabe, M.D., Ph.D.^1,2*, Hiroki Akiyama, M.D., Ph.D.^2*, Yoshihiro Umezawa, M.D., Ph.D.^2*, Ayako Nogami, M.D., Ph.D., BPharm², Osamu Miura, M.D., Ph.D.² and Norihiko Kawamata, M.D., Ph.D.^1,2

¹Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
²Department of Hematology, TMDU, Tokyo, Japan

Mark Eric Kohler, MD, PhD¹, Zachary Walsh^2*, Kole Degolier^2* and Terry J. Fry, MD¹

¹Center for Cancer and Blood Disorders, Children's Hospital Colorado - University of Colorado Anschutz, Aurora, CO
²University of Colorado Anschutz, Aurora, CO

Devikha Chandrasekaran, M.S.^1*, Quy Le, PhD^2*, Mary Prieve, PhD^1*, Carrie A Stoltzman, PhD^1*, Jody Cook, BS^1*, Joseph M Blake, BS^1*, Erin B Massey, MS^1*, Soheil Meshinchi, MD, PhD³ and Colleen Delaney, MD, MSc¹

¹Deverra Therapeutics, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Rsrch. Ctr., Seattle, WA